Roche Holding AG (NEO:ROG)

Market Cap	387.54B
Revenue (ttm)	108.88B
Net Income (ttm)	16.17B
Shares Out	n/a
EPS (ttm)	20.14
PE Ratio	23.97
Forward PE	13.76
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	5,671
Open	20.33
Previous Close	20.33
Day's Range	20.33 - 20.33
52-Week Range	18.42 - 24.41
Beta	n/a
RSI	57.26
Earnings Date	Oct 20, 2025

About Roche Holding AG

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tumors, dermatology, haemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It also provides in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and others; diagn...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1896
• Employees: 103,249
• Stock Exchange: Cboe Canada
• Ticker Symbol: ROG

Financial Performance

In 2024, Roche Holding AG's revenue was 62.40 billion, an increase of 3.23% compared to the previous year's 60.44 billion. Earnings were 8.28 billion, a decrease of -28.01%.

Financial numbers in CHF